Literature DB >> 3922759

Ca 125 and Ca 19-9: two cancer-associated sialylsaccharide antigens on a mucus glycoprotein from human milk.

F G Hanisch, G Uhlenbruck, C Dienst, M Stottrop, E Hippauf.   

Abstract

The cancer-associated antigens Ca 125 and Ca 19-9 were demonstrated by radioimmunoassay to form structural units of a mucus glycoprotein in human milk taken from healthy women four days after parturition. The glycoprotein precipitated with the casein fraction at pH 4.6 and was completely absent in the whey as judged from Ca 19-9 assay. It could be effectively enriched by phenol-saline extraction from soluble milk proteins and further purified by gel filtration on Sephacryl S300 and Sephacryl S400. The active component with a bouyant density of 1.41 g/ml in isopycnic density gradient centrifugation (CsCl) shared common physico-chemical and chemical characteristics of mucus glycoproteins. Carbohydrates representing about 68% by weight were conjugated to protein by alkali-labile linkages, exclusively and were essentially free of D-mannose. Activities of Ca 125 and Ca 19-9 were both destroyed by treatment with periodate, mild alkali or neuraminidase suggesting the antigens are sialylated saccharides bound to protein by alkali-labile linkages. The fraction of monosialylated saccharide alditols isolated after reductive beta-elimination from the mucus glycoprotein was shown to inhibit monoclonal antibodies anti-(Ca 125) and anti-(Ca 19-9) in radioimmunoassay.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922759     DOI: 10.1111/j.1432-1033.1985.tb08929.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

Review 1.  Mucin glycoproteins in neoplasia.

Authors:  Y S Kim; J Gum; I Brockhausen
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

2.  CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. I. Immunohistochemical detection.

Authors:  A Scharl; G Crombach; M Vierbuchen; H Müsch; A Bolte
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  An antibody-lectin sandwich assay for the determination of CA125 antigen in ovarian cancer patients.

Authors:  R Madiyalakan; M Kuzma; A A Noujaim; M R Suresh
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

4.  Characterization of the binding specificity of Anguilla anguilla agglutinin (AAA) in comparison to Ulex europaeus agglutinin I (UEA-I).

Authors:  S E Baldus; J Thiele; Y O Park; F G Hanisch; J Bara; R Fischer
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

5.  Biochemical and morphological differences between CA125 isolated from healthy women and patients with epithelial ovarian cancer from Tunisian population.

Authors:  Houda Bouanène; Walid Saibi; Moncef Mokni; Badreddine Sriha; L Ben Fatma; H Ben Limem; S Ben Ahmed; Ali Gargouri; Abdelhédi Miled
Journal:  Pathol Oncol Res       Date:  2011-09-07       Impact factor: 3.201

6.  Purification and immunochemical characterization of ascitic fluid glycoproteins containing certain tumor-associated and blood group antigen markers.

Authors:  M Venegas; L Liu; L Lovell; L E Davis; B Anderson; T Wilbanks; M Hass; G Manderino; H Rittenhouse
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

7.  A two-site lectinoenzymatic assay for determination of tumour marker glycoproteins in rectal secretions.

Authors:  T F Orntoft; J Jepsen; P V Hansen; U Raundahl; N C Langkilde
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

8.  Role of SPan-1 antigen in adhesion of human colon cancer cells to vascular endothelium.

Authors:  N Yamada; Y S Chung; T Sawada; M Okuno; M Sowa
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

9.  Immunoreactive determinants of CA 125 in women with endometriosis.

Authors:  O A Mojiminiyi; M E Bramwell; S H Kennedy; B J Shepstone; S M Humm; D H Barlow
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

Review 10.  Deciphering the molecular nature of ovarian cancer biomarker CA125.

Authors:  Florian Weiland; Karina Martin; Martin K Oehler; Peter Hoffmann
Journal:  Int J Mol Sci       Date:  2012-08-22       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.